You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Dow
McKesson
Medtronic
AstraZeneca
Baxter
Harvard Business School

Last Updated: April 7, 2020

DrugPatentWatch Database Preview

ADZENYS ER Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which patents cover Adzenys Er, and what generic alternatives are available?

Adzenys Er is a drug marketed by Neos Theraps Inc and is included in one NDA. There are three patents protecting this drug.

This drug has two patent family members in two countries.

The generic ingredient in ADZENYS ER is amphetamine. There are fifty-five drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the amphetamine profile page.

US ANDA Litigation and Generic Entry Outlook for Adzenys Er

Indicators of Generic Entry

< Available with Subscription >

  Start Trial

Drug patent expirations by year for ADZENYS ER
Drug Prices for ADZENYS ER

See drug prices for ADZENYS ER

Recent Clinical Trials for ADZENYS ER

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Duke UniversityPhase 2
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Phase 2

See all ADZENYS ER clinical trials

Pharmacology for ADZENYS ER
Synonyms for ADZENYS ER
.alpha.-Methylbenzeneethanamine
.alpha.-Methylbenzeneethaneamine
.alpha.-Methylphenethylamine
.alpha.-Methylphenethylamine, d-form
.alpha.-Methylphenylethylamine
.beta.-Aminopropylbenzene
.beta.-Phenylisopropylamin
.beta.-Phenylisopropylamine
(.+/-.)-.alpha.-Methylphenethylamine
(.+/-.)-.alpha.-Methylphenylethylamine
(.+/-.)-.beta.-Phenylisopropylamine
(.+/-.)-Benzedrine
(.+/-.)-Desoxynorephedrine
(+-)-alpha-Methylbenzeneethanamine
(+-)-alpha-Methylphenethylamine
(+-)-alpha-Methylphenylethylamine
(+-)-Benzedrine
(+)-.alpha.-Methylphenethylamine
(+)-.alpha.-Methylphenylethylamine
(+/-)-Amphetamine solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material
(+/-)-Amphetamine solution, 100 mug/mL in methanol, ampule of 1 mL, certified reference material
(+/-)-Benzedrine
(+/-)-beta-Phenylisopropylamine
(+/-)-Desoxynorephedrine
(Phenylisopropyl)amine
(plusmn)-amphetamine
(S)-.alpha.-Phenylethylamine
(S)-(+)-.beta.-Phenylisopropylamine
1-Methyl-2-phenylethylamine
1-Phenyl-2-amino-propan
1-Phenyl-2-amino-propan [German]
1-Phenyl-2-aminopropane
1-Phenyl-2-aminopropane (VAN)
1-Phenyl-2-propanamine
1-Phenyl-2-propylamine
1-phenylpropan-2-amine
2-Amino-1-phenylpropane
3-AMINO-1-PROPYLBENZENE
3-Phenyl-2-propylamine
3-phenylpropan-2-amine
300-62-9
3797-EP2275420A1
3797-EP2295439A1
3797-EP2298734A2
3797-EP2298742A1
3797-EP2298779A1
3797-EP2305219A1
3797-EP2305648A1
3797-EP2305656A1
3797-EP2308867A2
3797-EP2308870A2
3797-EP2311801A1
3797-EP2311802A1
3797-EP2311803A1
3797-EP2314571A2
3797-EP2371814A1
41820-21-7
60-15-1
Actedron
Adderal
Adderall XR
Adipan
AI3-02438
Allodene
alpha-methyl phenethylamine
ALPHA-METHYL-BENZENEETHANAMIDE (SEE ALSO DL-AMPHETAMINE SULFATE)
alpha-Methylbenzeneethaneamine
alpha-Methylphenethylamine
alpha-Methylphenylethylamine
Amfetamin (TN)
Amfetamina [INN-Spanish]
Amfetamina [Italian]
Amfetamine
Amfetamine (INN)
Amfetamine [INN:BAN]
amfetaminum
Amfetaminum [INN-Latin]
Amphetamin
AMPHETAMINE
AMPHETAMINE (SEE ALSO: D-AMPHETAMINE (51-64-9) & AMPHETAMINE SULFATE (60-13-9))
Amphetamine mixture with Dextroamphetamine
Amphetamine resin complex
Amphetamine salts
Amphetamine Sulfate (2:1)
amphetamine-
AMPHETAMINE, (D)
Amphetamine, its salts, optical isomers, and salts of its optical isomers
Anfetamina [Spanish]
Anorexide
Anorexine
BDBM50005246
Benzebar
Benzedrine
Benzeneethanamine, .alpha.-methyl-
Benzeneethanamine, .alpha.-methyl-, (.+/-.)-
Benzeneethanamine, .alpha.-methyl-, (.alpha.S)-
Benzeneethanamine, .alpha.-methyl-, (S)-
Benzeneethanamine, (S)-
Benzeneethanamine, alpha-methyl-
Benzeneethanamine, alpha-methyl-, (+-)-
Benzolone
beta-Aminopropylbenzene
beta-Aminopropylbenzene (VAN)
beta-phenyl-isopropylamine
beta-Phenylisopropylamin
beta-Phenylisopropylamin [German]
beta-Phenylisopropylamine
C07514
CHEBI:132233
CHEBI:2679
CHEMBL405
component of Amodex
component of Biphetamine
d-.alpha.-Methylphenethylamine
D-1-Phenyl-2-aminopropan
d/l-Amphetamine hydrochloride
D07445
DB-047697
DB00182
DEA No. 1100
DELCOBESE
Desoxynorephedrin
Desoxynorephedrine
Dexacaps
Dexedrine
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
DivK1c_000991
DL-.alpha.-Methylphenethylamine
dl-1-Phenyl-2-aminopropane
dl-alpha-Methylphenethylamine
dl-Amphetamine
DL-Amphetamine solution, 1 mg/mL in methanol, drug standard
dl-Benzedrine
DTXSID4022600
Dyanavel XR
EINECS 200-458-3
EINECS 206-096-2
Elastonon
Euphodyn (Salt/Mix)
Fabedrine (Salt/Mix)
Fenamin (Salt/Mix)
Fenopromin
Fenylo-izopropylaminyl
Fenylo-izopropylaminyl [Polish]
Finam
FT-0631912
FT-0694835
GTPL4804
HMS503G03
HSDB 3287
IDI1_000991
Isoamycin
Isoamyne
Isomyn
KBio1_000991
KWTSXDURSIMDCE-UHFFFAOYSA-N
L000864
levo-Amphetamine
Levoamphetamine
LS-1148
LS-1428
MCULE-4193952437
Mecodrin
Mydrial
NINDS_000991
Noclon (Salt/Mix)
Norephedrane
Norephedrine, deoxy-
Novydrine
NSC 27159
NSC-27159
NSC-73713
NSC27159
NSC73713
NT-0201
Oktedrin
Oprea1_447423
Oraldrina (Salt/Mix)
Ortedrine
Ortenal (Salt/Mix)
Percomon
Phenamine
Phenedrine
Phenethylamine, .alpha.-methyl-
Phenethylamine, .alpha.-methyl-, (.+/-.)-
Phenethylamine, (+)-
Phenethylamine, alpha-methyl-
Phenethylamine, alpha-methyl-, (+-)-
Phenethylamine, alpha-methyl, (+-)-
Phenethylamine, d-
Phenethylamine, D-.alpha.-methyl-
Profamina
Protioamphetamine
Psychedrine
Q179452
rac-(2R)-1-phenylpropan-2-amine
rac-Amphetamine
rac-Amphetamine 1.0 mg/ml in Methanol
racemic-Desoxynor-ephedrine
S(+)-Amphetamine
SCHEMBL8858
Simpatina
Stimulan (Salt/Mix)
Sympametin (Salt/Mix)
Thyramine
Vapedrine (Salt/Mix)
WLN: ZY1&1R
WLN: ZY1&1R -D
Zedrine (Salt/Mix)

US Patents and Regulatory Information for ADZENYS ER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Neos Theraps Inc ADZENYS ER amphetamine SUSPENSION, EXTENDED RELEASE;ORAL 204325-001 Sep 15, 2017 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Neos Theraps Inc ADZENYS ER amphetamine SUSPENSION, EXTENDED RELEASE;ORAL 204325-001 Sep 15, 2017 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Neos Theraps Inc ADZENYS ER amphetamine SUSPENSION, EXTENDED RELEASE;ORAL 204325-001 Sep 15, 2017 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
McKesson
Medtronic
AstraZeneca
Baxter
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.